San Raffaele
San Raffaele
Italy, Milan
Giorgia Mangili
34 years of experience
accreditations :
Clinic is certified :
| Italy | Turkey | Austria | |
| Оophorectomy | - | from $3,270 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Ovarian cancer surgery | - | from $2,700 | from $25,000 |
| Omentectomy | - | from $4,500 | from $15,000 |
| Laparoscopic oophorectomy (ovary removal surgery) | - | from $7,392 | - |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Ovarian cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ovarian cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ovarian cancer treatment journey.
Head of the Medical Gynecological Oncology Group at San Raffaele – Dr. Mangili specializes in rare gynecological tumors and fertility preservation in oncology.
Prof. Montorsi has performed over 8,000 urology and andrology surgeries, specializing in minimally invasive and robotic techniques.
Dr. Giorgia Garganese is the Director of the Gynecology and Breast Care Center at Mater Olbia Hospital. She also leads the hospital’s Women’s Care Center. She specializes in minimally invasive and guided surgery for breast and gynecologic cancers. Her main focus is on oncoplastic techniques and vulvar cancers. Dr. Garganese has performed more than 2,000 surgical procedures.
She is an Assistant Professor of Obstetrics and Gynecology at the Catholic University in Rome. She is also a faculty member at the Royal College of Surgeons in England. Dr. Garganese coordinates research projects on new cancer treatments, prognostic markers, therapeutic targets, and advanced ultrasound imaging for women’s cancers.